Ameritas Investment Partners, Inc. Unity Biotechnology, Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.29 $560 - $1,290	-1,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.3 - $3.17 $1,300 - $3,170	1,000 New	1,000 $1,000
Q2 2021 Aug 06, 2021	SELL	$4.15 - $6.3 $12,064 - $18,314	-2,907 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$5.28 - $9.67 $4,509 - $8,258	854 Added 41.6%	2,907 $25,000
Q4 2018 Feb 12, 2019	BUY	$10.76 - $17.25 $17,624 - $28,255	1,638 Added 394.7%	2,053 $33,000
Q2 2018 Aug 13, 2018	BUY	$12.76 - $16.94 $5,295 - $7,030	415 New	415 $6,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $34M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.